BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25108493)

  • 1. Influence of coronary anatomy and SYNTAX Score on the variations in revascularization strategies for patients with multivessel disease.
    Schwalm JD; Wijeysundera HC; Tu JV; Guo H; Kingsbury KJ; Natarajan MK
    Can J Cardiol; 2014 Oct; 30(10):1155-61. PubMed ID: 25108493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.
    Shen L; Hu S; Wang H; Xiong H; Zheng Z; Li L; Xu B; Yan H; Gao R
    J Am Coll Cardiol; 2013 Jun; 61(25):2525-33. PubMed ID: 23623906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.
    Capodanno D; Capranzano P; Di Salvo ME; Caggegi A; Tomasello D; Cincotta G; Miano M; Patané M; Tamburino C; Tolaro S; Patané L; Calafiore AM; Tamburino C
    JACC Cardiovasc Interv; 2009 Aug; 2(8):731-8. PubMed ID: 19695541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
    Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
    JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Centered Decision-Making of Revascularization Strategy for Left Main or Multivessel Coronary Artery Disease.
    Kim C; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Am J Cardiol; 2018 Dec; 122(12):2005-2013. PubMed ID: 30309626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial.
    Farooq V; Serruys PW; Garcia-Garcia HM; Zhang Y; Bourantas CV; Holmes DR; Mack M; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Diletti R; Papafaklis MI; de Vries T; Morel MA; van Es GA; Mohr FW; Dawkins KD; Kappetein AP; Sianos G; Boersma E
    J Am Coll Cardiol; 2013 Jan; 61(3):282-94. PubMed ID: 23265332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy.
    Farooq V; Girasis C; Magro M; Onuma Y; Morel MA; Heo JH; Garcia-Garcia H; Kappetein AP; van den Brand M; Holmes DR; Mack M; Feldman T; Colombo A; Ståhle E; James S; Carrié D; Fournial G; van Es GA; Dawkins KD; Mohr FW; Morice MC; Serruys PW
    EuroIntervention; 2013 Mar; 8(11):1277-85. PubMed ID: 23537954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYNTAX Score and Outcomes of Coronary Revascularization in Diabetic Patients.
    Kundu A; Sardar P; O'Day K; Chatterjee S; Owan T; Dawn Abbott J
    Curr Cardiol Rep; 2018 Mar; 20(5):28. PubMed ID: 29572680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of variations in initial treatment strategies for stable ischemic heart disease.
    Bennell MC; Qiu F; Kingsbury KJ; Austin PC; Wijeysundera HC
    CMAJ; 2015 Jul; 187(10):E317-E325. PubMed ID: 25991840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization.
    Chakravarty T; Buch MH; Naik H; White AJ; Doctor N; Schapira J; Mirocha JM; Fontana G; Forrester JS; Makkar R
    Am J Cardiol; 2011 Feb; 107(3):360-6. PubMed ID: 21256999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the SYNTAX revascularization index to quantify reasonable level of incomplete revascularization after percutaneous coronary intervention.
    Généreux P; Campos CM; Farooq V; Bourantas CV; Mohr FW; Colombo A; Morel MA; Feldman TE; Holmes DR; Mack MJ; Morice MC; Kappetein AP; Palmerini T; Stone GW; Serruys PW
    Am J Cardiol; 2015 Jul; 116(2):174-86. PubMed ID: 25983123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid coronary revascularization in 100 patients with multivessel coronary disease.
    Repossini A; Tespili M; Saino A; Di Bacco L; Giroletti L; Rosati F; Bisleri G; Muneretto C
    Ann Thorac Surg; 2014 Aug; 98(2):574-80; discussion 580-1. PubMed ID: 24968765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing of SYNTAX score performing fractional flow reserve in multivessel coronary artery disease.
    Novara M; D'Ascenzo F; Gonella A; Bollati M; Biondi-Zoccai G; Moretti C; Omedè P; Sciuto F; Sheiban I; Gaita F
    J Cardiovasc Med (Hagerstown); 2012 Jun; 13(6):368-75. PubMed ID: 22499002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
    Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
    JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years.
    Mohr FW; Rastan AJ; Serruys PW; Kappetein AP; Holmes DR; Pomar JL; Westaby S; Leadley K; Dawkins KD; Mack MJ
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):130-40. PubMed ID: 21168023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
    Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.